7Serafini AN. Therapy of metastatic bone pain[J]. J Nucl Med, 2001 ;429(6) :895- 906.
8Nair N. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases [ J ]. J Nucl Med, 1999 ;40(2 ) :256 - 261.
9Papatheofanis FJ. Decreased serum E-selectin concentration after 89Sr-choride therapy for metastic prostate cancer bone pain[J]. J Nucl Med, 2000;41(6):1021 -1024.
10Shah-Syed GM, Maken RN, Muzzaffar N et al. Effective and economical option for pain palliation in prostate cancer with skeletal metastses :32P therapy revisited [ J]. Nucl Med Commun, 1999 ;20(8) :697 -702.
8Serafini AN,Houston SJ,Resche I,et al.Palliation of pain associated with metastaticbone cancer using samarium-153lexidronam:a double-blind placebocontrolledclinical trial.J Clin Oncol,1998,16(4):1574
9Maxon HR,Tomas SR,Herzberg VS,et al.186Rehydroxyethylidene diphosponatefor the treatment of painful osseous metastasis.Semin Nucl Med,1992,22(1):23
10Tian JH;Zhang JM;Hou QT.Mulitcentre trial on the efficacy and toxicity of single-dose 153 Sm-ethylene diamine tetramethylene phosphonate as a palliative treatment for painful skeleal metastases in China,1999.
